T Fayers. Show Affiliations »
Abstract
Entities: Chemical
Mesh: See more » Angiogenesis Inhibitors/therapeutic useAntibodies, Monoclonal/therapeutic useAntibodies, Monoclonal, HumanizedBevacizumabDouble-Blind MethodHumansMacular Degeneration/drug therapyProspective StudiesRandomized Controlled Trials as TopicRanibizumab
Substances: See more » Angiogenesis InhibitorsAntibodies, MonoclonalAntibodies, Monoclonal, HumanizedBevacizumabRanibizumab
Year: 2011 PMID: 21350573 PMCID: PMC3178136 DOI: 10.1038/eye.2011.18
Source DB: PubMed Journal: Eye (Lond) ISSN: 0950-222X Impact factor: 3.775